Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 16Gynecologic 3Thoracic 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Adrenocortical Carcinoma 6Thyroid Carcinoma, Anaplastic 4Neoplasm Metastasis 4Sarcoma 3Pheochromocytoma 3Thyroid Neoplasms 2Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Ovarian Neoplasms 2Neurofibrosarcoma 2Neuroendocrine Tumors 2Neoplasms 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Kidney Neoplasms 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Head and Neck Neoplasms 2Fibrosarcoma 2Endometrial Neoplasms 2Thyroid Cancer, Papillary 1Somatostatinoma 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Mesothelioma, Malignant 1

Interventions

tipifarnib 1cixutumumab 1cabozantinib 1amino-acid, glucose, and electrolyte solution 1Radiotherapy 1LY2940680 1Ifosfamide 1Filgrastim 1Doxorubicin 1Cytoreduction Surgical Procedures 1Cisplatin 1Chemotherapy, Adjuvant 1Biological Factors 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdomyosarcoma × Doxorubicin × Endocrine × Clear all
NCT00002641 2014-08-08

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
350 enrolled
EndocrineGenitourinaryGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Kidney Neoplasms, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Pheochromocytoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡